Advanced search
Publication Cover
Expert Review of Dermatology Volume 8, 2013 - Issue 2
Journal homepage
4
Views
3
CrossRef citations to date
0
Altmetric
Perspective

Methodology and clinical utility of ultrasound-guided fine-needle aspiration cytology of lymph nodes in melanoma patients

Gregor Schäfer Department of Dermatology, Venerology and Allergology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. [email protected]; Department of Dermatology, Venerology and Allergology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. [email protected]
,
Alexander MM Eggermont Cancer Institute Gustave Roussy, Villejuif/Paris-Sud, France; Cancer Institute Gustave Roussy, Villejuif/Paris-Sud, France
&
Christiane A Voit Department of Dermatology, Venerology and Allergology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Department of Dermatology, Venerology and Allergology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany
Pages 145-153 | Published online: 10 Jan 2014

References

  • Hirschfeld H. Über isolierte aleukämische Lymphadenose der Haut. Z Krebsforsch. 11, 397–407 (1912).
  • Diamantis A, Magiorkinis E, Koutselini H. Fine-needle aspiration (FNA) biopsy: historical aspects. Folia Histochem. Cytobiol. 47(2), 191–197 (2009).
  • van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. New developments in sentinel node staging in melanoma: controversies and alternatives. Curr. Opin. Oncol. 22(3), 169–177 (2010).
  • Pharis DB. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy. Dermatol. Ther. 18(6), 397–406 (2005).
  • Lejeune FJ. The impact of surgery on the course of melanoma. Recent Results Cancer Res. 160, 151–157 (2002).
  • Voit C, Mayer T, Kron M et al. Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients. Cancer 91(12), 2409–2416 (2001).
  • Hölzel D, Engel J, Löhrs U. Elective lymph node dissections – still a standard in cancer surgery? Zentralbl. Chir. 133(6), 582–589 (2008).
  • Zeelen U, Binder T, Bauer U, Weber L, Schoengen A. The value of fine-needle aspiration cytology in the after-care of malignant melanoma. Hautarzt. 41(1), 34–38 (1990).
  • Rossi CR, Mocellin S, Scagnet B et al. The role of preoperative ultrasound scan in detecting lymph node metastasis before sentinel node biopsy in melanoma patients. J. Surg. Oncol. 83(2), 80–84 (2003).
  • Voit C, Mayer T, Proebstle TM et al. Ultrasound-guided fine-needle aspiration cytology in the early detection of melanoma metastases. Cancer 90(3), 186–193 (2000).
  • Murali R, Doubrovsky A, Watson GF et al. Diagnosis of metastatic melanoma by fine-needle biopsy: analysis of 2,204 cases. Am. J. Clin. Pathol. 127(3), 385–397 (2007).
  • Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 39(2), 456–466 (1977).
  • Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127(4), 392–399 (1992).
  • Krishnamurthy S, Sneige N, Bedi DG et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5), 982–988 (2002).
  • Altomare V, Guerriero G, Carino R et al. Axillary lymph node echo-guided fine-needle aspiration cytology enables breast cancer patients to avoid a sentinel lymph node biopsy. Preliminary experience and a review of the literature. Surg. Today 37(9), 735–739 (2007).
  • Veronesi U, Adamus J, Bandiera DC et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N. Engl. J. Med. 297(12), 627–630 (1977).
  • Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 41(3), 948–956 (1978).
  • Balch CM, Soong SJ, Bartolucci AA et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann. Surg. 224(3), 255–263; discussion 263 (1996).
  • Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351(9105), 793–796 (1998).
  • Morton DL, Thompson JF, Cochran AJ et al.; MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 355(13), 1307–1317 (2006).
  • Wong SL, Balch CM, Hurley P et al.; American Society of Clinical Oncology; Society of Surgical Oncology. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J. Clin. Oncol. 30(23), 2912–2918 (2012).
  • Ross MI, Gershenwald JE. How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? Ann. Surg. Oncol. 15(3), 670–673 (2008).
  • van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat. Rev. Clin. Oncol. 7(8), 446–454 (2010).
  • Xing Y, Bronstein Y, Ross MI et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J. Natl Cancer Inst. 103(2), 129–142 (2011).
  • Schoengen A, Binder T, Faiss S, Weber L, Zeelen U. Fine needle aspiration cytology of metastatic malignant melanoma. Improvement of results with ultrasound control. Hautarzt. 44(11), 703–707 (1993).
  • Voit CA, van Akkooi AC, Eggermont AM et al. Fine needle aspiration cytology of palpable and nonpalpable lymph nodes to detect metastatic melanoma. J. Natl Cancer Inst. 103(23), 1771–1777 (2011).
  • Gupta SK, Rajwanshi AK, Das DK. Fine needle aspiration cytology smear patterns of malignant melanoma. Acta Cytol. 29(6), 983–988 (1985).
  • Saqi A, McGrath CM, Skovronsky D, Yu GH. Cytomorphologic features of fine-needle aspiration of metastatic and recurrent melanoma. Diagn. Cytopathol. 27(5), 286–290 (2002).
  • Garbe C, Schadendorf D, Stolz W et al. Short German guidelines: malignant melanoma. J. Dtsch Dermatol. Ges. 6(Suppl. 1), 9–14 (2008).
  • Voit C, Kron M, Schäfer G et al. Ultrasound-guided fine needle aspiration cytology prior to sentinel lymph node biopsy in melanoma patients. Ann. Surg. Oncol. 13(12), 1682–1689 (2006).
  • Kahle B, Hoffend J, Wacker J, Hartschuh W. Preoperative ultrasonographic identification of the sentinel lymph node in patients with malignant melanoma. Cancer 97(8), 1947–1954 (2003).
  • Voit CA, van Akkooi AC, Schäfer-Hesterberg G et al. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J. Clin. Oncol. 27(30), 4994–5000 (2009).
  • Rettenbacher T. Sonography of peripheral lymph nodes part 1: normal findings and B-image criteria. Ultraschall Med. 31(4), 344–362 (2010).
  • Ulrich J, van Akkooi AJ, Eggermont AM, Voit C. New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLN biopsy). Expert Rev. Anticancer Ther. 11(11), 1693–1701 (2011).
  • Voit C, Van Akkooi AC, Schäfer-Hesterberg G et al. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma. J. Clin. Oncol. 28(5), 847–852 (2010).
  • Voit CA, Schäfer-Hesterberg G, Kron M et al. Impact of molecular staging methods in primary melanoma: reverse-transcriptase polymerase chain reaction (RT-PCR) of ultrasound-guided aspirate of the sentinel node does not improve diagnostic accuracy, but RT-PCR of peripheral blood does predict survival. J. Clin. Oncol. 26(35), 5742–5747 (2008).
  • Rossi CR, Seno A, Vecchiato A et al. The impact of ultrasound scanning in the staging and follow-up of patients with clinical stage I cutaneous melanoma. Eur. J. Cancer 33(2), 200–203 (1997).
  • Catalano O, Siani A. Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread. Curr. Probl. Diagn. Radiol. 39(1), 30–36 (2010).
  • Rubaltelli L, Beltrame V, Tregnaghi A, Scagliori E, Frigo AC, Stramare R. Contrast-enhanced ultrasound for characterizing lymph nodes with focal cortical thickening in patients with cutaneous melanoma. AJR Am. J. Roentgenol. 196(1), W8–12 (2011).
  • Agnese DM, Abdessalam SF, Burak WE Jr, Magro CM, Pozderac RV, Walker MJ. Cost–effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery 134(4), 542–547; discussion 547 (2003).
  • Bastiaannet E, Uyl-de Groot CA, Brouwers AH et al. Cost–effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma. Ann. Surg. 255(4), 771–776 (2012).
  • van Akkooi AC, Voit CA, Verhoef C, Eggermont AM. Potential cost–effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up. Ann. Surg. Oncol. 17(2), 660–662; author reply 663 (2010).
  • Hookim K, Roh MH, Willman J et al. Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma. Cancer Cytopathol. 120(1), 52–61 (2012).
  • Armato SG 3rd, Roberts RY, Kocherginsky M et al. Assessment of radiologist performance in the detection of lung nodules: dependence on the definition of ‘truth’. Acad. Radiol. 16(1), 28–38 (2009).
  • Eggermont AM, Suciu S, Testori A et al. Ulceration and stage are predictive of interferon efficacy in melanoma: results of the Phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur. J. Cancer 48(2), 218–225 (2012).
  • Eggermont AM, Suciu S, MacKie R et al.; EORTC Melanoma Group. Post-surgery adjuvant therapy with intermediate doses of interferon α 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet 366(9492), 1189–1196 (2005).
  • Eggermont AM, Suciu S, Santinami M et al.; EORTC Melanoma Group. Adjuvant therapy with pegylated interferon α-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised Phase III trial. Lancet 372(9633), 117–126 (2008).
  • Eggermont AM, Suciu S, Testori A et al. Long-term results of the randomized Phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon α-2b versus observation in resected stage III melanoma. J. Clin. Oncol. 30(31), 3810–3818 (2012).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.